Episode 1: Lessons learned from the ProACT, ProHOSP and ProREAL studies. The keys to making procalcitonin work in your antimicrobial stewardship program
15m
·
Emergency Medicine News - Current Procalcitonin Utilization and Publications
·
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Devendra N. Amin, MD, Medical Director of Critical Care Services, Medical/Surgical ICU and Neurocritical Care ICU at Morton Plant Hospital, Clearwater, FL, about the importance of PCT protocol adherence to optimize antimicrobial stewardship.
Sponsored by bioMérieux, Inc.
The episode Episode 1: Lessons learned from the ProACT, ProHOSP and ProREAL studies. The keys to making procalcitonin work in your antimicrobial stewardship program from the podcast Emergency Medicine News - Current Procalcitonin Utilization and Publications has a duration of
15:49. It was first published
More episodes from Emergency Medicine News - Current Procalcitonin Utilization and Publications
Episode 7: The Power of PCR and PCT Testing for Severe Acute Respiratory Infections in the Emergency Department
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Daniel Feinstein, MD, FACP, ACRP-PI, Medical Director, Critical Care, Novant Health, about the outcomes and benefits associated with the use of syndromic PCR testing and procalcitonin in the emergency department for patients with suspected and confirmed respiratory infections such as community-acquired pneumonia and COVID-19.
Opinions expressed in this podcast are not necessarily those of bioMérieux, Inc.
Episode 6: New Risk Model in the ED
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Charles B. Cairns, MD, the Walter H. and Leonore Annenberg Dean of the College of Medicine, Senior Vice President for Medical Affairs, and Professor of Medicine and Emergency Medicine at Drexel University, about the new potential for care utilizing host response biomarkers, pathogen identification and surveillance as well as newly published research.
Opinions expressed in this podcast are not necessarily those of bioMérieux, Inc
Episode 5: The Advantages of Using Procalcitonin and CLARION™ for Emergency Physicians
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Michael R. Broyles, BSPharm, RPh, PD, PharmD, Director of Clinical Pharmacy and Laboratory Services, Five Rivers Medical Center, Arkansas, about the advantages of using procalcitonin and data analytics for emergency physicians.
Opinions expressed in this podcast are not necessarily those of bioMérieux, Inc.
Episode 4: Diagnostic and Management Challenges of Influenza During the COVID-19 Pandemic
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Charles B. Cairns, MD, the Walter H. and Leonore Annenberg Dean of the College of Medicine, Senior Vice President for Medical Affairs, and Professor of Medicine and Emergency Medicine at Drexel University.
Sponsored by bioMérieux, Inc.
Episode 3: Interpreting Procalcitonin (PCT) in the New CAP Guidelines
David F. Gaieski, MD, Associate Professor, Emergency Medicine, Jefferson University Hospitals, Philadelphia, interviews Daniel Feinstein, MD, Adult Intensivist and Clinical Associate Professor, Medicine, University of North Carolina. He has extensive research in antibiotic administration and is a pioneer in antibiotic stewardship and sepsis care.
Sponsored by bioMérieux, Inc.